Berlin, Germany

Maik Gollasch

This inventor holds 5 USPTO granted patents. Top assignees: Medtronic, Inc., Other. Active years: 2010-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maik Gollasch. Retrieved from https://idiyas.com/inventor/maik-gollasch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 20.0

Average Co-Inventor Count = 2.0

ph-index = 4

Forward Citations = 63(Granted Patents)


Company Filing History:


Years Active: 2010-2014

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Maik Gollasch in Sleep Apnea and Heart Failure Treatment

Introduction

Maik Gollasch is a notable inventor based in Berlin, Germany. He has made significant contributions to the fields of medical technology, particularly in the treatment of sleep apnea and congestive heart failure. With a total of 5 patents to his name, Gollasch's work focuses on innovative devices and methods that enhance patient care.

Latest Patents

One of Gollasch's latest patents involves a device for detecting and treating sleep apnea. This device evaluates whether an episode of sleep apnea is occurring in patients suffering from chronic sleep apnea disorder. It includes circuitry that responds to cardiac signals generated by the heart. The device's switching circuitry diverts the heart signal through both high and low impedance paths, allowing a differential amplifier to process the resulting signal pairs. This analysis helps determine changes in the patient's ventilation, which can indicate an episode of sleep apnea. If such an episode is detected, a stimulus generator delivers appropriate electrical therapy to induce ventilation and terminate the apnea episode.

Another significant patent by Gollasch presents an improved method of vagal stimulation for treating patients with congestive heart failure. This method evaluates the physiological status of the patient by deriving thoracic or cardiac impedance and ventilation solely from cardiac signals (EKG). The derived data is used to control the application of stimulating electrical pulses to the patient's vagus nerve, adjusting the heart rate to alleviate congestive heart failure. The system accommodates changes in the patient's state, such as transitioning from rest to physical exercise, by modifying the vagal stimulation therapy accordingly.

Career Highlights

Throughout his career, Maik Gollasch has worked with prominent companies, including Medtronic, Inc. His experience in the medical technology sector has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Gollasch has collaborated with notable professionals in his field, including Eckhard U Alt. These collaborations have contributed to the advancement of his inventions and the impact they have on patient care.

Conclusion

Maik Gollasch's contributions to medical technology, particularly in the treatment of sleep apnea and heart failure, showcase his innovative spirit and dedication to improving patient outcomes. His patents reflect a commitment to advancing healthcare through technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…